Deficiencies in the function of CaMKIIα have been implicated in a range of diseases including schizophrenia, addiction, depression, epilepsy, and neurodevelopmental disorders (Robison, 2014; Chia et al., 2018). This evidence concerns the gene CAMK2A and schizophrenia.